Correlation Between Elevation Oncology and Enlivex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elevation Oncology and Enlivex Therapeutics, you can compare the effects of market volatilities on Elevation Oncology and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Enlivex Therapeutics.

Diversification Opportunities for Elevation Oncology and Enlivex Therapeutics

-0.24

Correlation Coefficient

Elevation Oncology  Enlivex Therapeutics

Very good diversification

The 3 months correlation between Elevation and Enlivex is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Elevation Oncology and Enlivex Therapeutics

Given the investment horizon of 90 days Elevation Oncology is expected to generate 1.4 times more return on investment than Enlivex Therapeutics. However, Elevation Oncology is 1.4 times more volatile than Enlivex Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  62.00  in Elevation Oncology on October 24, 2024 and sell it today you would earn a total of  9.00  from holding Elevation Oncology or generate 14.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Elevation Oncology  vs.  Enlivex Therapeutics

Elevation Oncology

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Elevation Oncology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting technical and fundamental indicators, Elevation Oncology showed solid returns over the last few months and may actually be approaching a breakup point.

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Elevation Oncology and Enlivex Therapeutics

The main advantage of trading using opposite Elevation Oncology and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.

The idea behind Elevation Oncology and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.